19 / 64
AFRICA
S17
CVJAFRICA • Volume 26, No 2, H3Africa Supplement, March/April 2015
Open Lab will partner with and contribute towards developing
NCD research capability at up to 10 African research centres.
A detailed search and evaluation of the relevant academic
and clinical laboratories will be conducted to identify optimal
partners. These centres will be recognised as emerging world-
class centres of excellence for R&D on NCDs in Africa, and will
attract and retain the next generation of scientific talent in Africa.
For more information please visit
www.gsk.com/africa-ncd-openlab.
References
1.
65th World Health Assembly closes with new global health measures.
http://www.who.int/mediacentre/news/releases/2012/wha65_ closes_20120526/en/index.html. Accessed 12 December 2014.
2.
A major victory at the World Health Assembly for NCDs.
http:// ncdalliance.org/news/major-victory-world-health-assembly-ncds.Accessed 12 December 2014.
3.
Alwan A. Global status report on noncommunicable diseases 2010.
Geneva: World Health Organization, 2011.
http://www.who.int/nmh/ publications/ncd_report2010/en/.Accessed 12 December 2014.
4.
Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in
sub-Saharan Africa.
Lancet
2010;
375
(9733): 2254–2266. DOI: 10.1016/
S0140-6736(10)60550-8.
5.
Dillon DG, Gurdasani D, Riha J,
et al.
Association of HIV and ART
with cardiometabolic traits in sub-Saharan Africa: a systematic review
and meta-analysis.
Int J Epidemiol
2013;
42
(6): 1754–1771. DOI:
10.1093/ije/dyt198.
6.
Witty A. New strategies for innovation in global health: a pharmaceu-
tical industry perspective.
Health Affairs
2011;
30
(1): 118–126. DOI:
10.1377/hlthaff.2010.0933.
7.
Tres Cantos Open Lab Foundation.
http://www.openlabfoundation.org.
Accessed 12 December 2014.
8.
GSK announces new strategic investments in Africa to increase access
to medicines, build capacity and deliver sustainable growth.
http://www. gsk.com/en-gb/media/press-releases/2014/gsk-announces-new-strategic investments-in-africa-to-increase-access-to-medicines-build-capacity- and-deliver-sustainable-growth/.Accessed 12 December 2014.
9.
GSK Pharmaceuticals: our pharmaceuticals business develops
and makes a broad range of medicines to treat both acute and
chronic diseases.
http://www.gsk.com/en-gb/about-us/what-we-do/ pharmaceuticals/. Accessed 11 March 2015.
10. GSK and Save the Children form unique partnership to save the
lives of one million children.
http://www.gsk.com/en-gb/media/press- releases/2013/gsk-and-save-the-children-form-unique-partnership-to- save-the-lives-of-one-million-children/. Accessed 12 December 2014.